Lyophilization of solid lipid nanoparticles loaded with brucine
Qingxia Guan, Yuwei Zhao, Zhenqiang Liu, Yufei Feng, Hua Xiao-dan, Zhao Yi-jun
Abstract
Qingxia Guan, Yuwei Zhao, Zhenqiang Liu, Yufei Feng, Hua Xiao-dan, Zhao Yi-jun
Abstract
Objectivet: To prepare and evaluate the quality of brucine solid lipid nanoparticles( B-SLN)lyophilized powder. Methods: Emulsification evaporation was employed to prepare B-SLN. Freeze-drying support agent and freeze drying process were screened to optimize the prescription of the lyophilized powder. TEM was used to observe B-SLN morphology; particle size and Zeta potential were measured by laser particle size analyzer; HPLC was used to determine the entrapment efficiency; the characterization was performed by differential thermal analysis. Results: B-SLN was spherical solid particles which dispersed uniformly. The average particle size was( 101. 3 ± 2. 2) nm,potential was(- 21. 6 ± 1. 6) mv,encapsulation rate was( 64. 88 ± 3. 9) %,and drug loading was( 2. 75 ± 20. 03) %. Differential thermal analysis showed that brunice existed in a non-crystalline state in BSLN,indicating that brunice may exist in solid lipid nanoparticles in a molecular or amorphous state. Conclusion:Using 0. 7% trehalose as cryoprotectant can obtain B-SLN with the smallest particle size,highest entrapment efficiency,good stability,and desirable appearance and redispersibility by the most reasonable preparation process.This study provides a reliable reference for future research.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objectivet: To prepare and evaluate the quality of brucine solid lipid nanoparticles( B-SLN)lyophilized powder. Methods: Emulsification evaporation was employed to prepare B-SLN. Freeze-drying support agent and freeze drying process were screened to optimize the prescription of the lyophilized powder. TEM was used to observe B-SLN morphology; particle size and Zeta potential were measured by laser particle size analyzer; HPLC was used to determine the entrapment efficiency; the characterization was performed by differential thermal analysis. Results: B-SLN was spherical solid particles which dispersed uniformly. The average particle size was( 101. 3 ± 2. 2) nm,potential was(- 21. 6 ± 1. 6) mv,encapsulation rate was( 64. 88 ± 3. 9) %,and drug loading was( 2. 75 ± 20. 03) %. Differential thermal analysis showed that brunice existed in a non-crystalline state in BSLN,indicating that brunice may exist in solid lipid nanoparticles in a molecular or amorphous state. Conclusion:Using 0. 7% trehalose as cryoprotectant can obtain B-SLN with the smallest particle size,highest entrapment efficiency,good stability,and desirable appearance and redispersibility by the most reasonable preparation process.This study provides a reliable reference for future research.
Key concepts: Solid lipid nanoparticle, Particle size, Brucine, Zeta potential, Differential scanning calorimetry, Freeze-drying, Chromatography, Nanoparticle